Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites

Head and Neck

Volumn 33, Issue 6, 2011, Pages 847-855

  Dahlstrom, Kristina R ^a   Li, Guojun ^a   Tortolero Luna, Guillermo ^b   Wei, Qingyi ^a   Sturgis, Erich M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

head and neck neoplasms; HPV16; human papillomavirus; oropharynx; sexual behavior

Indexed keywords

ADENOIDECTOMY; ADULT; AGED; ARTICLE; CHLAMYDIA; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; GENITAL HERPES; GONORRHEA; HEAD AND NECK CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF NON OROPHARYNGEAL; SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX; SYPHILIS; TONSILLECTOMY; TUMOR LOCALIZATION; WART VIRUS;

ADULT; AGE DISTRIBUTION; AGED; CANCER CARE FACILITIES; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; ODDS RATIO; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; REFERENCE VALUES; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SEXUAL BEHAVIOR; TEXAS; TUMOR VIRUS INFECTIONS;

EID: 79955913112     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21550     Document Type: Article

References (36)

1. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100: 1672-1694.
2. Sturgis EM, Cinciripini PM,. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110: 1429-1435. (Pubitemid 47463055)
3. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619. (Pubitemid 351264356)
4. Ernster JA, Sciotto CG, O'Brien MM, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 2007; 117: 2115-2128. (Pubitemid 351339584)
5. Shiboski CH, Schmidt BL, Jordan RC,. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005; 103: 1843-1849. (Pubitemid 40563256)
6. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956. (Pubitemid 46740304)
7. Kreimer AR, Clifford GM, Boyle P, Franceschi S,. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475. (Pubitemid 40270113)
8. Dahlstrom KR, Adler-Storthz K, Etzel CJ, et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 2003; 9: 2620-2626. (Pubitemid 36842105)
9. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-1131. (Pubitemid 32285233)
10. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998; 90: 1626-1636. (Pubitemid 28523437)
11. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720. (Pubitemid 30365531)
12. Baseman JG, Koutsky LA,. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32 Suppl 1: S16-24. (Pubitemid 40332585)
13. Dillner J, Andersson-Ellström A, Hagmar B, Schiller J,. High risk genital papillomavirus infections are not spread vertically. Rev Med Virol 1999; 9: 23-29. (Pubitemid 29088064)
14. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML,. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-1269.
15. Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189: 686-698. (Pubitemid 38270923)
16. Kreimer AR, Alberg AJ, Viscidi R, Gillison ML,. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence. Sex Transm Dis 2004; 31: 247-256. (Pubitemid 38401925)
17. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766-772. (Pubitemid 38076410)
18. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP,. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114: 806-816. (Pubitemid 40344442)
19. Shaw AR,. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented? Gynecol Oncol 2005; 99 (3 Suppl 1): S246-248. (Pubitemid 41774359)
20. Devaraj K, Gillison ML, Wu TC,. Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma. Crit Rev Oral Biol Med 2003; 14: 345-362. (Pubitemid 44560789)
21. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT,. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994; 86: 494-499. (Pubitemid 24111004)
22. Dillner J, Kallings I, Brihmer C, et al. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 1996; 173: 1394-1398. (Pubitemid 26286798)
23. Olsen AO, Dillner J, Gjøen K, Magnus P,. Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA. Genitourin Med 1997; 73: 131-135. (Pubitemid 27204856)
24. Ritchie JM, Smith EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104: 336-344. (Pubitemid 36249816)
25. Hemminki K, Dong C, Frisch M,. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev 2000; 9: 433-437. (Pubitemid 32065958)
26. Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007; 99: 1634-1643.
27. Balamurugan A, Ahmed F, Saraiya M, et al. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer 2008; 113 (10 Suppl): 2919-2925.
28. Chaturvedi AK, Kleinerman RA, Hildesheim A, et al. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol 2009; 27: 967-973.
29. Rose Ragin CC, Taioli E,. Second primary head and neck tumor risk in patients with cervical cancer-SEER data analysis. Head Neck 2008; 30: 58-66. (Pubitemid 351158322)
30. Sikora AG, Morris LG, Sturgis EM,. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg 2009; 135: 402-405.
31. Silins I, Kallings I, Dillner J,. Correlates of the spread of human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2000; 9: 953-959.
32. Kjaer SK, Dahl C, Engholm G, Bock JE, Lynge E, Jensen OM,. Case-control study of risk factors for cervical neoplasia in Denmark. II. Role of sexual activity, reproductive factors, and venereal infections. Cancer Causes Control 1992; 3: 339-348.
33. Stone KM, Zaidi A, Rosero-Bixby L, et al. Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology 1995; 6: 409-414.
34. Smith JS, Herrero R, Bosetti C, et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002; 94: 1604-1613. (Pubitemid 35378725)
35. Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP,. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med 2006; 3: e138.
36. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E,. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer 2003; 106: 896-904. (Pubitemid 37071668)